Your browser doesn't support javascript.
loading
A five-mRNA signature associated with post-translational modifications can better predict recurrence and survival in cervical cancer.
Ju, Mingyi; Qi, Aoshuang; Bi, Jia; Zhao, Lan; Jiang, Longyang; Zhang, Qiang; Wei, Qian; Guan, Qiutong; Li, Xueping; Wang, Lin; Wei, Minjie; Zhao, Lin.
Afiliação
  • Ju M; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang City, Liaoning, China.
  • Qi A; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang City, Liaoning, China.
  • Bi J; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang City, Liaoning, China.
  • Zhao L; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang City, Liaoning, China.
  • Jiang L; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang City, Liaoning, China.
  • Zhang Q; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang City, Liaoning, China.
  • Wei Q; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang City, Liaoning, China.
  • Guan Q; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang City, Liaoning, China.
  • Li X; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang City, Liaoning, China.
  • Wang L; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang City, Liaoning, China.
  • Wei M; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang City, Liaoning, China.
  • Zhao L; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang City, Liaoning, China.
J Cell Mol Med ; 24(11): 6283-6297, 2020 06.
Article em En | MEDLINE | ID: mdl-32306508

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article